EX-10.58 3 dex1058.htm DRUG PRODUCT DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT [*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission...Drug Product Development and Clinical Supply Agreement • May 5th, 2020 • Delaware
THIS DRUG PRODUCT DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT (the “Agreement”) is effective as of the 28th day of April 2006 (the “Effective Date”).
Drug Product Development and Clinical Supply AgreementDrug Product Development and Clinical Supply Agreement • November 10th, 2008 • California
Bio-Path Holdings, Inc., a corporation organized and existing under the laws of the State of Utah, with its principal offices located at 3293 Harrison Blvd., Suite 230, Ogden, UT 84403 (hereinafter referred to as “CLIENT”).
Drug Product Development and Clinical Supply AgreementDrug Product Development and Clinical Supply Agreement • January 9th, 2008 • Omeros Corp • California
OMEROS CORPORATION, a corporation organized and existing under the laws of Washington, with its principal offices located at 1420 Fifth Avenue, Suite 2600, Seattle, Washington 98101 (hereinafter referred to as “CLIENT”)
Drug Product Development and Clinical Supply AgreementDrug Product Development and Clinical Supply Agreement • September 28th, 2005 • Neurobiological Technologies Inc /Ca/ • Biological products, (no disgnostic substances) • Delaware
NEUROBIOLOGICAL TECHNOLOGIES, INC., a corporation organized and existing under the laws of Delaware, with its principal offices located at 3260 Blume Drive, Suite 500, Richmond, California 94806 (hereinafter referred to as “NTI”)
Drug Product Development and Clinical Supply AgreementDrug Product Development and Clinical Supply Agreement • May 15th, 2009 • Omeros Corp • Pharmaceutical preparations • California
OMEROS CORPORATION, a corporation organized and existing under the laws of Washington, with its principal offices located at 1420 Fifth Avenue, Suite 2600, Seattle, Washington 98101 (hereinafter referred to as “CLIENT”)
